"Findings suggest that pure autonomic failure may be a prodromal presentation of central alpha-synucleinopathies, and future ...
Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports ...
Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing scale ...
Multiple system atrophy (MSA) is an adult-onset, rapidly progressive neurodegenerative disorder characterised by the aggregation of α-synuclein in oligodendroglial cytoplasmatic inclusions.1 ...
Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.
As of Tuesday, April 21, Alterity Therapeutics Limited’s ATHE share price has dipped by 8.54%, which has investors questioning if this is right time to buy.
Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency AskBio Inc. (AskBio), a ...
Astronomers at The University of New Mexico have published new research confirming three bodies orbiting the dynamic exoplanet system TOI-201. They include a super-Earth (TOI-201 d), a warm Jupiter ...
A well-researched and thoughtfully assembled multi-room audio system is a thing of beauty. Gone are the days of fiddling with volume control switches and individual amplifiers for each room you want ...
The tiny zebrafish is helping researchers rapidly determine whether a newborn’s genetic mutation is likely to cause spinal muscular atrophy (SMA), one of the leading causes of infant mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results